Integra LifeSciences Holdings Corporation

NASDAQ:IART

Medical - Devices

Healthcare
$13.86 +4.71%

+$0.81 today

Market cap
$1.08B
Beta
1.25
P/E (TTM)
-2.8
EPS (TTM)
-$6.44
52W Low $8.70High $18.26

Volume 0.58M

Average 0.96M

IART Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Integra LifeSciences Holdings CorporationNASDAQ: IART

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 57.2%

Gross margin was 57.2% in Q1 FY2026, up 6.4 pp from a year earlier. On a trailing-twelve-month basis it was 53.2%, down 0.3 pp year over year. Over 3 fiscal years it narrowed by 10.6 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
57.2%+7.7 pp QoQ
Last fiscal yearDec 2025
51.7%-3.1 pp YoY
LTMMar 2026
53.2%-0.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+6.4 pp——
1 year-3.1 pp——
3 years-10.6 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
51.7%
Year-over-year change
-3.1pp

Gross Margin vs competitors

How IART compares with its peers on the latest reported figures

  • IART's LTM Mar 2026 gross margin of 53.2% is the lowest of the 11 companies compared; the peer median is 66.6%.
  • Its year-over-year change of -0.3 pp is the 6th highest of 11, against a peer median of -0.0 pp.
  • Over three fiscal years its change of -10.6 pp compares with a peer median of -2.3 pp.
IART Competitors Peer median
Gross Margin for IART and competitors
Company Period LTM level YoY 3-year change
AXGNAxoGen, Inc.LTM Sep 202674.2% -0.6 pp-4.2 pp
OFIXOrthofix Medical Inc.LTM Mar 202669.0% +1.9 pp-6.1 pp
GMEDGlobus Medical, Inc.LTM Jun 202668.5% +5.8 pp-6.8 pp
SNNSmith & Nephew plcFY202568.3% -2.0 pp-2.7 pp
TELATELA Bio, Inc.LTM Jun 202667.8% +0.5 pp+2.4 pp
ATECAlphatec Holdings, Inc.LTM Mar 202665.3% -3.6 pp+3.2 pp
SYKStryker CorporationLTM Jun 202665.2% +2.3 pp+4.1 pp
AORTArtivion, Inc.LTM Mar 202662.9% -1.0 pp-3.3 pp
XTNTXtant Medical Holdings, Inc.LTM Mar 202662.3% +4.2 pp+7.5 pp
CNMDCONMED CorporationLTM Mar 202653.6% -1.9 pp-1.9 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202653.2% -0.3 pp-10.6 pp
Peer median (excluding IART) 66.6%-0.0 pp-2.3 pp

Competitors are the stored peer set for IART. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.54B1.56B1.54B1.61B1.64B
Cost of Revenue597.81M587.36M656.84M728.47M790.01M
Gross Profit944.64M970.31M884.74M882.06M845.23M
Gross Margin61.2%62.3%57.4%54.8%51.7%
Research & Development93.05M101.19M104.19M115.38M98.97M
Selling, General & Admin637.45M616.32M656.64M716.98M699.7M
Operating Expenses747.41M731.39M773.21M853.65M776.92M
Depreciation & Amortization123.67M121.12M123.51M140.5M151.05M
EBITDA366.33M384.6M255.96M193.29M(326.2M)
EBITDA Margin23.7%24.7%16.6%12.0%-19.9%
Operating Income197.23M238.92M111.53M28.41M68.32M
Operating Margin12.8%15.3%7.2%1.8%4.2%
Interest Income6.74M11.92M17.2M20.04M18.47M
Interest Expense50.4M49.59M51.38M70.63M86.26M
Other Income / Expenses17.45M(25.03M)(30.46M)(46.65M)(631.82M)
Income Before Tax214.68M213.89M81.07M(18.24M)(563.5M)
Pre-Tax Margin13.9%13.7%5.3%-1.1%-34.5%
Income Tax Expense45.6M33.34M13.33M(11.29M)(47.03M)
Net Income169.08M180.55M67.74M(6.94M)(516.47M)
Net Margin11.0%11.6%4.4%-0.4%-31.6%
EPS (Basic)2.002.180.87(0.09)(6.73)
EPS (Diluted)1.982.160.84(0.09)(6.73)
Weighted Avg Shares84.7M83M78.17M77.01M76.75M
Weighted Avg Shares (Diluted)85.49M83.52M80.34M77.01M76.75M

Integra LifeSciences Holdings Corporation

NASDAQ:IART

Intrinsic Alpha fair value

Locked

Current Price

$13.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.